Rare diseases
Investigational molecules
Locations
Nygaardsgaten 114, 5008 Bergen, Norway
Bergenbio ASA’s clinical research is centred on advanced and metastatic non-squamous non-small cell lung cancer, with particular attention to patients lacking actionable mutations. The sponsor’s work in this area includes disease settings where treatment options are limited and where tumour biology may influence response to therapy.
Research activity also includes lung cancer with STK11 mutation, reflecting interest in molecularly defined patient groups within thoracic oncology.
Bergenbio ASA runs clinical trials in conditions such as Non-small cell lung cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
